TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
LobSor Pharmaceuticals AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 11,791 | 36,638 | 26,668 |
Financial expenses | 12 | 100 | 248 |
Earnings before taxes | 34,693 | 46,650 | -28,678 |
EBITDA | 34,044 | 55,549 | -17,057 |
Total assets | 101,182 | 72,030 | 65,207 |
Current assets | 69,097 | 32,824 | 14,769 |
Current liabilities | 15,766 | 740 | 40,894 |
Equity capital | 85,417 | 71,290 | 22,101 |
- share capital | 47 | 49 | 52 |
Employees (average) | 3 | 3 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.4% | 99.0% | 33.9% |
Turnover per employee | 3,930 | 12,213 | 26,668 |
Profit as a percentage of turnover | 294.2% | 127.3% | -107.5% |
Return on assets (ROA) | 34.3% | 64.9% | -43.6% |
Current ratio | 438.3% | 4435.7% | 36.1% |
Return on equity (ROE) | 40.6% | 65.4% | -129.8% |
Change turnover | -23,746 | 11,813 | 18,449 |
Change turnover % | -67% | 48% | 224% |
Chg. No. of employees | 0 | 2 | 0 |
Chg. No. of employees % | 0% | 200% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.